SEC Form 4 · accession 0001179110-18-001910
Esperion Therapeutics, Inc. · ESPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger S Newton
Director
Period of report
Feb 7, 2018
Accepted (ET)
Feb 9, 2018 · 5:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 12, 2017 | G | 12,000 | $0.00 | D | 617,683 | D | |
| Common Stock | Feb 7, 2018 | M | 34,651 | $6.99 | A | 652,334 | D | |
| Common Stock | Feb 7, 2018 | F | 3,608 | $6.99 | D | 648,726 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to Purchase Common StockF1 | $6.99 | Feb 7, 2018 | M | 34,651 | D | — | Feb 12, 2018 | Common Stock | 34,651 | 0 | D |
Explanation of responses
- F1Fully exercisable as of the date hereof.